STSS.NASDAQSharps Technology INC
10-K/A: Sharps Technology Files Amendment to 10-K to Include Compensation Recovery Policy
Sentiment:
Form 10-K/A Amendment
Sharps Technology, Inc. files an amendment to its annual report on Form 10-K to include the company's Compensation Recovery Policy.
Summary
- Sharps Technology, Inc. is filing Amendment No. 1 on Form 10-K/A to its annual report for the fiscal year ended December 31, 2024.
- The amendment includes the company's Compensation Recovery Policy as Exhibit 99.1.
- The original 10-K was filed with the Securities and Exchange Commission on March 27, 2024.
- The purpose of the amendment is solely to include the Compensation Recovery Policy.
- The amendment does not update any other information in the original 10-K and should be read in conjunction with it.
- As of June 30, 2024, the aggregate market value of the registrant's common stock held by non-affiliates was $6,541,788.
- As of March 25, 2025, 16,333,897 shares of common stock were issued and outstanding.
Sentiment
Score: 7
Explanation: The document is primarily a procedural filing. The inclusion of a compensation recovery policy is generally viewed positively as it enhances corporate governance.
Positives
- The adoption of a Compensation Recovery Policy aligns Sharps Technology with regulatory requirements and best practices in corporate governance.
- The policy aims to recover erroneously awarded compensation, promoting accountability and fairness.
- The policy is not discretionary, except in limited circumstances, which promotes consistent application.
Industry Context
Compensation recovery policies are becoming increasingly common in response to regulatory requirements and investor expectations for greater accountability in executive compensation.
Comparison to Industry Standards
- Many publicly traded companies, including those listed on the Nasdaq Capital Market like Sharps Technology, have adopted similar compensation recovery policies to comply with Section 10D of the Securities Exchange Act of 1934 and Exchange Act Rule 10D-1.
- These policies are designed to align executive compensation with financial performance and protect shareholder interests in the event of accounting restatements.
- Companies like General Electric, Johnson & Johnson, and Pfizer have similar clawback policies in place, allowing them to recover incentive-based compensation from executives in certain circumstances.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Recovery Policy | Adoption of a Compensation Recovery Policy in accordance with Section 10D of the Securities Exchange Act of 1934. | 2025-04-15 | The policy allows the company to recover erroneously awarded incentive-based compensation from executive officers in the event of an accounting restatement, promoting accountability and aligning executive compensation with financial performance. |
Stakeholder Impact
- Shareholders: The Compensation Recovery Policy aims to protect shareholder value by allowing the company to recover erroneously awarded compensation.
- Executive Officers: The policy affects executive officers by making them subject to potential recovery of incentive-based compensation in the event of an accounting restatement.
Key Dates
| Date | Description |
|---|---|
| 2020-06-10 | Date of Asset/Share Purchase Agreement among the Company, Safegard Medical (Hungary) Ktf, Numan Holding Ltd, Cortrus Services SA and Latitude Investments Limited |
| 2020-06-24 | Date of Amendment No. 1 to Asset/Share Purchase Agreement |
| 2020-08-27 | Date of Amendment No. 2 to Asset/Share Purchase Agreement |
| 2020-10-28 | Date of Amendment No. 3 to Asset/Share Purchase Agreement |
| 2021-01-01 | Date of Consulting Agreement between the Company and Berry Berler |
| 2021-07-19 | Date of Amendment No. 4 to Asset/Share Purchase Agreement |
| 2021-09-09 | Date of Employment Agreement between the Company and Robert Hayes |
| 2021-09-23 | Date of Letter from Numan Holding Ltd |
| 2021-12-14 | Date of Note Purchase Agreement among the Company and the purchasers named therein |
| 2022-02-28 | Date of Amendment No. 5 to Asset/Share Purchase Agreement |
| 2022-03-18 | Original filing date of Registrant's Registration Statement on Form S-1; No. 333-263715, as amended |
| 2022-03-22 | Date of Plan and Agreement of Merger between Sharps Technology, Inc., a Wyoming corporation, and Sharps Technology, Inc., a Nevada corporation |
| 2022-12-28 | Date of Certificate of Amendment to Designation, filed on December 28, 2022 |
| 2024-01-01 | Start of fiscal year ended December 31, 2024 |
| 2024-03-27 | Original filing date of the Annual Report on Form 10-K for the year ended December 31, 2024 |
| 2024-06-30 | Date used to calculate the aggregate market value of the registrant's common stock held by non-affiliates |
| 2024-12-31 | End of fiscal year |
| 2025-01-22 | Originally filed date of Registrant's Registration Statement on Form S-1; No. 333-284237 |
| 2025-03-25 | Date as of which 16,333,897 shares of the registrant's common stock were issued and outstanding |
| 2025-03-27 | Date of report from PKF O'Connor Davies LLP with respect to the consolidated financial statements of Sharps Technology, Inc. as of December 31, 2024 and 2023 |
| 2025-04-15 | Date of signatures for the Form 10-K/A |
Keywords
Compensation Recovery Policy, Form 10-K/A, Amendment, Financial Reporting, Executive Compensation, Sharps Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.